These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4204696)

  • 1. Letter: Enhancement of enzymatic activity in Fabry's disease.
    Christensen E
    N Engl J Med; 1974 Mar; 290(11):629-30. PubMed ID: 4204696
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
    Brady RO; Tallman JF; Johnson WG; Gal AE; Leahy WR; Quirk JM; Dekaban AS
    N Engl J Med; 1973 Jul; 289(1):9-14. PubMed ID: 4196713
    [No Abstract]   [Full Text] [Related]  

  • 3. Kidney transplantation in Fabry's disease.
    Philippart M; Franklin SS; Leeber DA; Hull AR; Peters PC
    N Engl J Med; 1973 Aug; 289(5):270-1. PubMed ID: 4197403
    [No Abstract]   [Full Text] [Related]  

  • 4. Enzyme transplantation in Fabry's disease.
    Krivit W; Desnick RJ; Bernlohr RW; Wold F; Najarian JS; Simmons RL
    N Engl J Med; 1972 Dec; 287(24):1248-9. PubMed ID: 4563680
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal transplantation in Fabry's disease.
    Peters PC; Leeber D; Hull AR; Philippart M
    Trans Am Assoc Genitourin Surg; 1972; 64():36-8. PubMed ID: 4569857
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Fabry's disease: correction of the enzymatic deficiency by renal transplantation.
    Desnick RJ; Allen KY; Simmons RL; Najarian JS; Krivit W
    J Lab Clin Med; 1971 Dec; 78(6):989-90. PubMed ID: 4943510
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme replacement therapy by renal allotransplantation in Fabry's disease.
    Clarke JT; Guttmann RD; Wolfe LS; Beaudoin JG; Morehouse DD
    N Engl J Med; 1972 Dec; 287(24):1215-8. PubMed ID: 4563677
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction of enzymatic deficiencies by renal transplantation: Fabry's disease.
    Desnick RJ; Simmons RL; Allen KY; Woods JE; Anderson CF; Najarian JS; Krivit W
    Surgery; 1972 Aug; 72(2):203-11. PubMed ID: 4559379
    [No Abstract]   [Full Text] [Related]  

  • 9. The biochemical abnormalities in Fabry's disease.
    Kint JA; Dacremont G
    Arch Int Physiol Biochim; 1970 Feb; 78(1):169-71. PubMed ID: 4100872
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of cross-reactive antigen in Fabry's disease.
    Beutler E; Kuhl W
    N Engl J Med; 1973 Sep; 289(13):694-5. PubMed ID: 4199465
    [No Abstract]   [Full Text] [Related]  

  • 11. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes.
    Desnick RJ; Allen KY; Desnick SJ; Raman MK; Bernlohr RW; Krivit W
    J Lab Clin Med; 1973 Feb; 81(2):157-71. PubMed ID: 4683418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fabry-Anderson's disease].
    Andratschke C
    Fortschr Med; 1975 Dec; 93(34):1697-702. PubMed ID: 811519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide trihexosidosis (fabry's disease) without skin lesions.
    Clarke JT; Knaack J; Crawhall JC; Wolfe LS
    N Engl J Med; 1971 Feb; 284(5):233-5. PubMed ID: 5539345
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemistry of Fabry's disease].
    Kint JA; Dacremont G
    Arch Belg Dermatol Syphiligr; 1972; 28(3):245-50. PubMed ID: 4664703
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation.
    Philippart M; Franklin SS; Gordon A
    Ann Intern Med; 1972 Aug; 77(2):195-200. PubMed ID: 4565790
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiokeratoma corporis diffusum (Fabry's disease). Biochemical diagnosis in plasma].
    Atzpodien W; Kremer GJ; Schnellbacher E; Denk R; Haferkamp G; Bierbach H
    Dtsch Med Wochenschr; 1975 Feb; 100(9):423-6. PubMed ID: 803896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry's disease: structural or regulatory mutation?
    Beutler E; Kuhl W
    J Lab Clin Med; 1971 Dec; 78(6):987. PubMed ID: 5131867
    [No Abstract]   [Full Text] [Related]  

  • 18. Fabry's disease: normal alpha-galactosidase activity and urinary-sediment glycosphingolipid levels in two obligate heterozygotes.
    Avila JL; Convit J; Velazquez-Avila G
    Br J Dermatol; 1973 Aug; 89(2):149-57. PubMed ID: 4726891
    [No Abstract]   [Full Text] [Related]  

  • 19. Fabry's disease: absence of storage as a feature of liver sinus endothelium.
    Elleder M
    Acta Histochem; 1985; 77(1):33-6. PubMed ID: 3933254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry's disease: general clinical aspects.
    Carton D
    Arch Belg Dermatol Syphiligr; 1972; 28(3):239-43. PubMed ID: 4198230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.